Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats
Open Access
- 8 December 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 10, 561
Abstract
Magnesium sulfate (MgSO4) is the most widely used therapy in the clinic to prevent the progression of preeclampsia, a hypertensive disorder of pregnancy, to eclampsia. Eclampsia, manifested as unexplained seizures and/or coma during pregnancy or postpartum, accounts for ~13% of maternal deaths worldwide. While MgSO4 continues to be used in the clinic, the mechanisms by which it exerts its protective actions are not well understood. In this study, we tested the hypothesis that MgSO4 protects against placental ischemia-induced increases in brain water content and cerebrospinal fluid cytokines. To test this hypothesis, MgSO4 was administered via mini-osmotic pump (60 mg/day, i.p.) to pregnant and placental ischemic rats, induced by mechanical reduction of uterine perfusion pressure, from gestational day 14-19. This treatment regimen of MgSO4 led to therapeutic level of 2.8±0.6 mmol/L Mg in plasma. MgSO4 had no effect on improving placental ischemia-induced changes in mean arterial pressure, number of live fetuses, or fetal and placental weight. Placental ischemia increased, while MgSO4 prevented the increase in water content in the anterior cerebrum. Cytokine and chemokine levels were measured in the cerebrospinal fluid using a multi-plex assay. Results demonstrate that cerebrospinal fluid, obtained via the cisterna magna, had reduced protein, albumin, interleukin (IL)-17A, IL-18, IL-2, eotaxin, fractalkine, interferon gamma, vascular endothelial growth factor (VEGF), and macrophage inflammatory protein (MIP)-2 following MgSO4 treatment. These data support the hypothesis that MgSO4 offers neuroprotection by preventing placental ischemia-induced cerebral edema and reducing levels of cytokines/chemokines in the cerebrospinal fluid.Keywords
Funding Information
- National Institutes of Health (P20GM104357, P01HL051971, K99HL129192)
- American Heart Association (13POST16240000)
This publication has 70 references indexed in Scilit:
- Placental Ischemia Impairs Middle Cerebral Artery Myogenic Responses in the Pregnant RatHypertension, 2011
- Plasma From Preeclamptic Women Increases Blood-Brain Barrier PermeabilityHypertension, 2010
- Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin ExpressionHypertension, 2009
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant RatHypertension, 2006
- Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant RatHypertension, 2005
- Pre-eclampsiaThe Lancet, 2005
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasoundBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Mg2+–Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vesselsCanadian Journal of Physiology and Pharmacology, 1987